Streetbeat News

Analyst Ratings

BWA

Analysts have provided various ratings for BorgWarner (NYSE:BWA) within the last quarter, with 1 bullish, 3 somewhat bullish, and 4 indifferent. The average price target is $46.22, representing an upside from the current price of $32.59. This average is a 9.02% decrease from the previous average price target of $50.80.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 4:00 pm

SBGI

Sinclair (NASDAQ:SBGI) has received two bullish and two indifferent analyst ratings in the last quarter. The average 12-month price target for Sinclair, according to four analysts, is $18.88, a decrease of 14.95% from the previous average price target of $22.20.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 4:00 pm

GOLF

Acushnet Hldgs (NYSE:GOLF) has received 6 analyst ratings in the last quarter, with 3 being bullish and 3 indifferent. The average price target is $64.83, indicating an upside from the current price of $54.9. This average has increased by 7.16% from the previous average price target of $60.50.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 4:00 pm

RARE

Ultragenyx Pharmaceutical (NASDAQ:RARE) has received somewhat bullish ratings from four analysts in the last quarter, with an average price target of $104.5, implying an upside from the current price of $36.41. This average represents a 2.03% decrease from the previous average price target of $106.67.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 4:00 pm

AMD

The article provides a detailed analysis of Advanced Micro Devices (AMD) in comparison to its competitors in the Semiconductors & Semiconductor Equipment industry. The analysis reveals that AMD's P/E ratio is significantly higher than the industry average, suggesting a premium valuation. However, its P/B and P/S ratios are lower than the industry average, indicating potential undervaluation. AMD's ROE, EBITDA, gross profit, and revenue growth are lower than the industry average, suggesting potential challenges in profitability and growth. The company's debt-to-equity ratio is lower than its top 4 peers, indicating a favorable balance between debt and equity.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 4:00 pm

OTLK

Analysts have provided bullish ratings for Outlook Therapeutics (NASDAQ:OTLK) within the last quarter, with 3 bullish ratings and 2 indifferent ratings. The average 12-month price target for the company is $3.8, which has increased by 38.18% over the past month.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 4:00 pm

VSTO

Roth MKM analyst Matt Koranda maintains a Neutral rating on Vista Outdoor (NYSE:VSTO) and raises the price target from $25 to $26.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 3:57 pm

CURLF

TLLTF

TSNDF

VRNOF

Equity research firm Zuanic & Associates has initiated coverage of TILT Holdings (OTC:TLLTF) with an Overweight rating. The firm highlighted the value of TILT's vape hardware franchise and potential synergies between its plant-touching and vape divisions. TILT's cannabis business is gaining momentum in Massachusetts, Ohio, and Pennsylvania. The company's financial stability is also noted, with TILT well-placed to meet its debt maturities until the end of 2025. The firm's bullish case is based on TILT's earnings growth and a reduction in the peer discount.

Portfolio Pulse from Nicolás Jose Rodriguez

November 03, 2023 | 3:53 pm

PTON

Roth MKM analyst George Kelly maintains a 'Buy' rating on Peloton Interactive (NASDAQ:PTON) but has lowered the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 3:53 pm

GOLF

Roth MKM analyst George Kelly has maintained a Neutral rating on Acushnet Hldgs (NYSE:GOLF) and lowered the price target from $60 to $58.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 3:51 pm